LAS VEGAS, January 4, 2016 /PRNewswire/ --
- With High Frame Rate, Small Size and Low Power Consumption,
OmniVision's OVM6211 and SMI's Eye Tracking Platform Are Ready
for VR and AR Volume Markets
OmniVision's global shutter
CameraCubeChip[TM] will be
integrated into SMI's virtual reality (VR) and augmented reality
(AR) eye tracking platform as part of an alliance that aspires to
shape the future of the sector.
In a joint announcement today, coinciding with the Consumer
Electronics Show (CES) in Las
Vegas, OmniVision Technologies, Inc. (NASDAQ: OVTI), a
leading developer of advanced digital imaging solutions, and
SensoMotoric Instruments GmbH (SMI), a world leader in eye tracking
technology, said that the use of one of the industry's smallest
global shutter camera solutions will enable SMI's eye tracking
platform to deliver high frame rates and low latency, enabling
real-time, intuitive, and hands-free VR and AR experiences in
devices such as VR headsets and smart glasses.
"Previously we have integrated OmniVision's sensors to create
unique reference designs for desktop, mobile, and wearable VR and
AR with exceptional results. By leveraging OmniVision's latest
sensor technology, we are able to offer an extremely compact,
robust and fast eye tracking platform that can be easily integrated
into a wide range of displays," said Christian Villwock, director of SMI's OEM
Solutions Business. "The combination of high performance and low
power consumption in the OVM6211 aligns precisely with our advanced
eye-tracking technology, and is critical in pushing the frontiers
of natural user interfaces."
Will Foote, OmniVision's
partnership manager, added: "As the demand for VR and AR headsets
increases rapidly, not only for gaming devices but also for
professional, enterprise, academic and wider consumer applications,
the availability of intuitive, hands-free user interfaces can
become critical. We are excited to work alongside SMI, an industry
leader of nearly 25 years, and help shape the future of this
rapidly growing market segment."
Using OmniVision's 3 micron
OmniPixel3-GS[TM] global shutter
pixel, the OVM6211 features high sensitivity in near infrared (NIR)
wavelengths, minimizing the required power budget of the NIR light
source. The OVM6211captures full resolution (400x400 pixels) video
at 120 frames per second. OmniVision's
CameraCubeChip[TM] technology
enables the OVM6211's extremely compact form factor of just 3.23 x
3.23 x 3.92 mm, making it ideal for space constrained devices.
SMI's "works with everyone" eye tracking platform is proven for
VR/AR applications, streaming highly accurate eye tracking data
such as gaze vector and 3D eyeball position. It is calibration-free
for quick and easy setup and has fully automatic slip compensation,
allowing users to move or take the headset on or off without any
impact on data robustness.
About OmniVision
OmniVision Technologies (NASDAQ: OVTI) is a leading developer of
advanced digital imaging solutions. Its award-winning CMOS imaging
technology enables superior image quality in many of today's
consumer and commercial applications, including mobile phones,
notebooks, tablets and webcams, digital still and video cameras,
security and surveillance, entertainment devices, automotive and
medical imaging systems. Find out more at http://www.ovt.com.
About SMI
SensoMotoric Instruments (SMI) is a world leader in eye tracking
technology, developing and marketing eye & gaze tracking
systems for scientists and professionals, OEM and medical solutions
for a wide range of applications. Find out more at
http://www.smivision.com. Follow @SMIeyetracking on Facebook,
Flickr, YouTube and Twitter.
Safe-Harbor Language
Certain statements in this press release, including
statements regarding the expected benefits, performance,
capabilities, and potential market appeal of the
OVM6211 and/or systems incorporating the
OVM6211 are forward-looking statements that are subject to
risks and uncertainties. These risks and uncertainties, which could
cause the forward-looking statements and OmniVision's
results to differ materially, include, without limitation:
potential errors, design flaws or other problems with
OVM6211 and/or systems incorporating the OVM6211,
customer acceptance, demand, and other risks detailed from time to
time in OmniVision's Securities and Exchange
Commission filings and reports, including, but not limited to,
OmniVision's annual report filed on Form 10-K and
quarterly reports filed on Form 10-Q. OmniVision expressly
disclaims any obligation to update information contained in any
forward-looking statement.
OmniVision® and the OmniVision logo are registered trademarks
of OmniVision Technologies, Inc. OmniPixel3-GS™ and CameraCubeChip™
are trademarks of OmniVision Technologies, Inc. All other
trademarks are the property of their respective
owners.
# # #
Media Contacts
For SMI:
Stefanie Gehrke,
+49(0)172-3808-537, stefanie.gehrke@smi.de
For Omnivision:
Cameron Crowe, Impress Labs,
+1-415-735-8420, cameron@impresslabs.com
Scott Foster, OmniVision
Technologies, +1-408-567-3077, sfoster@ovt.com
SOURCE SensoMotoric Instruments GmbH (SMI)